NCBI PubMed NLMPubMed
Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
  Limits Preview/Index History Clipboard Details    
About Entrez
spacer gif
back to About Entrez
back to About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby

Related Resources
Order Documents
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central

Privacy Policy

 Show: 

1: Rev Med Interne. 2000 Mar;21(3):282-4. Related Articles, Links
Click here to read 
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature]

[Article in French]

Pinzani V, Ginies E, Robert L, Peyriere H, Abbar M, Blayac JP.

Centre regional de pharmacovigilance, CHU de Montpellier, Montpellier, France.

INTRODUCTION: Venlafaxine is an antidepressant that selectively inhibits serotonin reuptake and is a norepinephrine inhibitor. Withdrawal syndromes can occur after abrupt drug discontinuation of long-term regimens. EXEGESIS: We report six cases of withdrawal symptoms after venlafaxine discontinuation. CONCLUSION: Physicians must be aware of the frequency, rapidity and potent severity of these withdrawal syndromes.

Publication Types:
  • Case Reports
  • Review
  • Review of Reported Cases

PMID: 10763190 [PubMed - indexed for MEDLINE]


 Show: